Hepatocyte ballooning

Papers on hepatocyte ballooning

13 papers1 new in 30 days

Monday, February 9

LancetFeb 9

Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial

Randomized trial in 84 peopleMetabolic dysfunction-associated steatohepatitis

Wednesday, October 23

Journal of Translational Internal MedicineOct 23

Effect of Weight Reduction on Histological Activity and Fibrosis of Lean Nonalcoholic Steatohepatitis Patient

Non-randomized trial in peopleMetabolic dysfunction-associated steatohepatitis